Comparison of RANTES expression in Crohn's disease and ulcerative colitis: an aid in the differential diagnosis?
BACKGROUND
RANTES (regulated on activation, normal T cell expressed and secreted) expression is increased in inflammatory bowel disease (IBD). RANTES is produced at higher levels in granulomatous conditions, so increased RANTES expression can be expected in Crohn's disease compared with ulcerative colitis.


OBJECTIVE
To compare RANTES expression between intestinal biopsy specimens of patients with Crohn's disease and those with ulcerative colitis.


METHODS
A prospective study of patients presenting with lower gastrointestinal symptoms at the Bahrain Specialist Hospital from July 2004 to April 2005 was carried out. Endoscopic colonic biopsy specimens were taken from every patient and subjected to (a) routine haematoxylin and eosin staining examination by light microscopy, (b) immunohistochemistry for examination of RANTES protein expression by light microscopy and (c) in situ hybridisation for examination of RANTES mRNA expression by light microscopy. RANTES expression was assessed and quantified.


RESULTS
58 patients were enrolled to the study. Of them, 40 had IBD (21 had Crohn's disease and 19 had ulcerative colitis), 15 were controls with normal colonic biopsy results or non-inflammatory lesions and 3 had colonic inflammatory lesions other than IBD. RANTES expression in lymphocytes or histiocytes was significantly higher (p = 0.04) in new patients with ulcerative colitis than in those with Crohn's disease analysed by immunohistochemistry (IHC).


CONCLUSIONS
RANTES expression in lymphocytes or histiocytes is significantly higher in patients with ulcerative colitis than in those with Crohn's disease. Hence, RANTES IHC can be an effective method for distinguishing between biopsy specimens of patients with ulcerative colitis from those of patients with Crohn's disease, where routine histological features are indeterminate. RANTES IHC may prove to be a useful technique for identifying early or equivocal granulomas.
Ansari
N
N
Department of Pathology, Arabian Gulf University, Bahrain. ansarnas@hotmail.com
Abdulla
J
J
Zayyani
N
N
Brahmi
U
U
Taha
S
S
Satir
A A
AA
D015415:Biomarkers / Q000378:metabolism; D001706:Biopsy; D018946:Chemokine CCL5 / Q000235:genetics / Q000378:metabolism*; D003093:Colitis, Ulcerative / Q000175:diagnosis* / Q000473:pathology; D003424:Crohn Disease / Q000175:diagnosis* / Q000473:pathology; D003937:Diagnosis, Differential; D015870:Gene Expression; D006801:Humans; D007413:Intestinal Mucosa / Q000378:metabolism; D008214:Lymphocytes / Q000378:metabolism; D011446:Prospective Studies; D012333:RNA, Messenger / Q000235:genetics; D012189:Retrospective Studies
D015415:Biomarkers; D018946:Chemokine CCL5; D012333:RNA, Messenger